Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal-L-C randomized trial

Yang, WY; Min, K; Zhou, ZG; Li, L; Xu, XJ; Zhu, DL; Rao, AV; Murthy, LS; Zhang, NX; Li, I; Niemoeller, E; Shang, SH

Yang, WY (reprint author), China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China.

DIABETES OBESITY & METABOLISM, 2018; 20 (2): 335

Abstract

AimsTo assess the effects on glycaemic control of lixisenatide vs placebo as add-on treatment to basal insulin (BI)metformin and effects on glycated h......

Full Text Link